Spermidine/spermine N1-acetyltransferase-1 as a diagnostic biomarker in human cancer

18Citations
Citations of this article
22Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Aim: SSAT-1 is an enzyme that plays a critical role in cell growth. Amantadine, a FDA-approved antiviral drug, is a substrate for SSAT-1. The utility of amantadine as an agent to demonstrate elevated SSAT-1 activity linked to cancer was conducted. Results: High levels of SSAT-1 expression were measured in tumor human cell lines, and in breast, prostate and lung tumor tissue. An increase in the urinary levels of acetylated amantadine in cancer patients was observed. Conclusion: Increases in SSAT-1 contents in tumor tissue could be of value in targeting cancers with high SSAT-1 expression for confirmation/quantification. The high levels of acetylated amantadine could be used as a simple and useful screening test for the presence of cancer.

Cite

CITATION STYLE

APA

Maksymiuk, A. W., Sitar, D. S., Ahmed, R., Cheng, B., Bach, H., Bagchi, R. A., … Ramjiawan, B. (2018). Spermidine/spermine N1-acetyltransferase-1 as a diagnostic biomarker in human cancer. Future Science OA, 4(10). https://doi.org/10.4155/fsoa-2018-0077

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free